Patients who underwent Exparel injection and On-Q implantation following autologous reconstruction were reviewed. Primary outcome measures included: Patient Controlled Analgesia (PCA) dose/frequency/ attempts/rejections, daily pain score, required oral postoperative pain medication, and return-to-ambulation. Postoperative oral pain medications were converted to morphine equivalent dosages for analysis. Pain scores were on a 010 scale and return-to-ambulation was calculated using the Braden scale. Bivariate statistics were performed to identify differences and similarities between the two groups.
RESULTS: 80 patients were reviewed; 40 received Exparel intraoperatively and 40 received the On-Q pump. Patients using the On-Q pump required significantly higher total doses from the PCA (p<0.001). There was no significant difference in return-to-ambulation on postoperative day 0,2,3,or 4, though patients using OnQ had a higher level of ambulation on postoperative day 1 (p=.033). There was no significant difference in pain scores on postoperative day 1, however, patients using On-Q required higher total doses of PCA for analgesia (p=0.008). For POD 2-5, the Exparel group reported higher pain scores, but required less medication to control their pain (p<0.001).
CONCLUSION:
Patients receiving Exparel require less doses of opioids on POD1, while no discernible difference is observed in the amount of oral pain medication between the two groups. The maximum benefit of Exparel is realized primarily in the first 24-48 postoperative hours. PURPOSE: Ventral hernia (VH) remains an inadequately addressed surgical problem. While advanced repair techniques have been the focus of the surgical community, patient reported outcome (PRO) measures are needed to ensure that the perspective of patients, being key stakeholders in hernia research, is included. Current hernia PRO measures were developed without patient input, greatly impairing the content validity of such instruments.
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QUALITATIVE ASSESSMENT OF OUTCOMES FOLLOWING VENTRAL
METHODS:
This cross-sectional, qualitative study examined the alignment of patient perceptions of VH repair to a conceptual hernia PRO framework using semi-structured, concept elicitation interviews of VH repair, recovery and satisfaction until saturation was reached. Thematic analysis using iterative methodologies, e.g. open coding and simultaneous data collection and analysis led to the revision of domains. Reliability and validation checks included interrater reliability using Cohen's kappa statistic (mean kappa = .99), member-checking and triangulation.
RESULTS:
Interviews with 15 patients revealed that the original hernia PRO conceptual framework aligned with the domains relevant to VH patients but required modification to represent the depth and range of patients' perceived experiences. The revised framework included seven domains: 1) Expectations, 2) Self and Others, 3) Surgeon and Surgical Team, 4) Sensation, 5) Function, 6) Appearance, and 7) Overall Satisfaction. Overall patient satisfaction was associated with two themes: 1) Provider-patient relationship and 2) Patient assessment of post-repair quality of life.
CONCLUSION:
While surgeons and patients share many goals regarding VH repair, key aspects of what matters most to patients has not been included in current VH PRO instruments. 
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FREE TISSUE TRANSFERS FOR HEAD AND NECK CANCER PATIENTS WITH END STAGE RENAL DISEASE ON DIALYSIS: ANALYSIS OF OUTCOMES USING THE TAIWAN'S NATIONAL HEALTH INSURANCE RESEARCH DATABASE
